ALKS
Price:
$48.34
Market Cap:
$8.11B
Alkermes plc, a biopharmaceutical company, engages in the research, development, and commercialization of pharmaceutical products to address unmet medical needs of patients in therapeutic areas in the United States, Ireland, and internationally. The company has a portfolio of proprietary commercial products for the treatment of opioid dependence, alcohol dependence, schizophrenia, bipolar I, and a pipeline of clinical and preclinical product candidates in development for neurological disorders. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ARISTADA INITIO for the treatment of schizophrenia in adults; VIVITROL for the treatm...[Read more]
Industry
Biotechnology
IPO Date
1991-07-16
Stock Exchange
NASDAQ
Ticker
ALKS
According to Alkermes plc’s latest financial reports and current stock price. The company's current Enterprise Value is 8.99B. This represents a change of 45.69% compared to the average of 6.17B of the last 4 quarters.
The mean historical Enterprise Value of Alkermes plc over the last ten years is 4.90B. The current 8.99B Enterprise Value has changed 18.25% with respect to the historical average. Over the past ten years (40 quarters), ALKS's Enterprise Value was at its highest in in the June 2026 quarter at 9.61B. The Enterprise Value was at its lowest in in the March 2020 quarter at 2.51B.
Average
4.90B
Median
4.45B
Minimum
3.29B
Maximum
8.52B
Discovering the peaks and valleys of Alkermes plc Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 15.64%
Maximum Annual Enterprise Value = 8.52B
Minimum Annual Increase = -45.92%
Minimum Annual Enterprise Value = 3.29B
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 3.56B | -21.63% |
| 2024 | 4.54B | 0.34% |
| 2023 | 4.53B | 3.67% |
| 2022 | 4.37B | 14.22% |
| 2021 | 3.82B | 15.64% |
| 2020 | 3.31B | 0.43% |
| 2019 | 3.29B | -28.30% |
| 2018 | 4.59B | -45.92% |
| 2017 | 8.49B | -0.35% |
| 2016 | 8.52B | -29.10% |
The current Enterprise Value of Alkermes plc (ALKS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
4.21B
5-year avg
4.16B
10-year avg
4.90B
Alkermes plc’s Enterprise Value is greater than PTC Therapeutics, Inc. (5.74B), greater than Arcellx, Inc. (6.75B), greater than Protagonist Therapeutics, Inc. (8.37B), greater than ACADIA Pharmaceuticals Inc. (4.28B), greater than TG Therapeutics, Inc. (8.50B), less than Arrowhead Pharmaceuticals, Inc. (13.33B), greater than Vaxcyte, Inc. (7.51B), greater than CRISPR Therapeutics AG (4.96B), greater than Akero Therapeutics, Inc. (4.32B), greater than Kymera Therapeutics, Inc. (8.59B),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 5.74B | $6.18B | |
| 6.75B | $6.73B | |
| 8.37B | $8.55B | |
| 4.28B | $4.51B | |
| 8.50B | $8.19B | |
| 13.33B | $12.14B | |
| 7.51B | $7.65B | |
| 4.96B | $4.59B | |
| 4.32B | $4.50B | |
| 8.59B | $8.66B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Alkermes plc using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Alkermes plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Alkermes plc's Enterprise Value?
What is the highest Enterprise Value for Alkermes plc (ALKS)?
What is the 3-year average Enterprise Value for Alkermes plc (ALKS)?
What is the 5-year average Enterprise Value for Alkermes plc (ALKS)?
How does the current Enterprise Value for Alkermes plc (ALKS) compare to its historical average?